GlassScriptPhysician profile
Michael S Wong
NPI 1235114703
$7,896.16
in general payments reported to CMS, 2019-2025
21 companies · $322 in 2025
The $322 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $990 · 2020: $517 · 2021: $321 · 2022: $4,685 · 2023: $984 · 2024: $78.68 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,384.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $3,956.63 | 2022-2023 | |
| Tela Bio, INC. | $1,148.79 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $377.33 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Sientra, INC. | $319.40 | 2019-2021 | |
| Integra Lifesciences Corporation | $315.76 | 2019-2020 | |
| Polarityte, INC. | $250.84 | 2019-2020 | |
| Innovation Technologies INC | $209.88 | 2020-2022 | |
| Allergan, INC. | $202.87 | 2019 | |
| Tei Biosciences INC | $129.51 | 2019 | |
| Idorsia Pharmaceuticals US INC | $128.81 | 2023 | Quviviq |
| Musculoskeletal Transplant Foundation INC. | $121.29 | 2025 | |
| Zimmer Biomet Holdings, INC. | $119.30 | 2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $113.36 | 2022 | |
| Acell, INC. | $112.44 | 2019 | |
| Mentor Worldwide LLC | $110.77 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $93.75 | 2021 | |
| Stryker Corporation | $75.48 | 2020 | |
| Osiris Therapeutics INC. | $36.26 | 2019 | |
| Biosense Webster, INC. | $26.82 | 2024 | Carto 3 |
| Novo Nordisk INC | $24.36 | 2022 | |
| Smith+Nephew, INC. | $22.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.